Physician
Gallenstein, George
Gallenstein, George was paid $320K by Medicaid between Jan 2018 and Dec 2023, across 14 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.
33Billing provider infoGALLENSTEIN, GEORGE
MAYSVILLE, KY 41056
MAYSVILLE, KY 41056
33aNPI1992747695assigned 06/10/2006
33bProvider typeFamily Medicine Physician
28Total paid$320K
24GClaims9,897
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Family Medicine Physician providers in Kentucky
Rank by total paid#115 of 352
Median peer was paid$90K
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,728 | $66K | |
| 2019 | 1,436 | $53K | |
| 2020 | 1,311 | $45K | |
| 2021 | 2,044 | $60K | |
| 2022 | 2,135 | $62K | |
| 2023 | 1,243 | $35K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 48% | 3,022 | 2,635 | $155K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 43% | 3,749 | 3,138 | $138K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.5% | 403 | 313 | $11K |
| 80305 | 1.7% | 708 | 638 | $5K | |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 1,196 | 1,074 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 405 | 201 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 97 | 84 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 92 | 77 | $830.41 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 44 | 39 | $633.10 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 22 | 21 | $271.68 |
| 99441 | <1% | 18 | 18 | $188.56 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 23 | 14 | $111.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.